 Home > Chemicals Industry > China Chemical > Under the new situation, how can pharmaceutical machinery companies stay behind in the market?

Under the new situation, how can pharmaceutical machinery companies stay behind in the market?

 Last Update: 2021-07-02
 Source: Internet
 Author: User

Tags

epoxy chemical formula

lab safety equipment

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

[ Market analysis of chemical machinery equipment network ] In recent years, with the promotion of policies such as centralized procurement and speeding up the approval of new drugs, the domestic innovative drug industry has developed rapidly.
How to bring new drugs to the market faster and better has always been the focus of attention of pharmaceutical companies.
As the upstream of the pharmaceutical industry, the pharmaceutical equipment industry is also facing challenges such as capacity upgrades, as well as opportunities for market demand growth.
So, under the new situation, how can pharmaceutical machinery companies stay behind in the market? The author believes that there are at least the following three aspects.

Chemical machinery and equipment network market analysis chemical machinery and equipment

Actively embrace digitalization

In order not to fall behind, the pharmaceutical equipment industry should closely follow the policy and adapt to the changes of the times.
The current is a digital age.
In recent years, the manufacturing industry, including the pharmaceutical equipment industry, has been supported by relevant policies such as "Made in China 2025".
Recently, it has been supported by *.
It can be said that the digitalization of the industry has become a trend.

For the pharmaceutical equipment industry, actively embracing digitalization on the one hand can improve management efficiency and reduce the production costs of enterprises; on the other hand, it is also conducive to ensuring the production of downstream pharmaceutical companies, improving product quality and safety, and assisting industrial transformation and upgrading.

Increase R&D investment

　　Concentrated investment and continuous research and development can enhance the core competitiveness of pharmaceutical machinery companies and harvest more innovative results.
However, compared with foreign pharmaceutical machinery companies, most domestic pharmaceutical machinery companies are mainly small and medium-sized, and their technology, capital, and resource capabilities are weak, and it is often difficult to work hard on R&D investment.
Judging from the R&D investment of large pharmaceutical companies in recent years, the annual R&D investment of companies with high investment accounts for only more than 10% of revenue, while others remain at least 5.
26%.

　　The industry believes that with the continuous development of pharmaceutical equipment technology and pharmaceutical technology, and the increasingly fierce market competition, domestic pharmaceutical companies can only increase their efforts in manufacturing processes, new material applications, and R&D investment in order to achieve a lower level of pharmaceutical products.
Transition to high value-added products.
Of course, in addition to the need for companies to pay attention to research and development, they also need more policy encouragement, support and guidance.

　　Improve innovation ability

　　With the transformation of the pharmaceutical industry in the direction of green, digital, and intelligent, and the people have higher and higher requirements for drug quality, industry supervision has become more and more stringent, and the innovative development of the pharmaceutical equipment industry is also constantly facing new demands and requirements.
For example, in terms of greening, environmental protection is currently one of the main directions for the transformation and upgrading of pharmaceutical equipment companies, and it is also a major test for the technological innovation capabilities of pharmaceutical machinery companies.
It is reported that in recent years, some large pharmaceutical machinery companies have used technologies such as energy-saving and environmentally friendly equipment and green intelligent manufacturing systems to promote the greening of pharmaceutical equipment and equipment manufacturing around the two major directions of green product research and development and green manufacturing process core processes.

　　It is worth mentioning that the innovation capability of an enterprise is not only embodied in technology and products, but also includes innovation in enterprise management, marketing and sales.
In terms of corporate management, if a pharmaceutical machinery company falls behind in its management, there is a risk of being eliminated by the market.
At present, many small and medium-sized pharmaceutical machinery companies generally lack excellent management teams and corporate management culture, leading to lack of innovation, cost wasting, insufficient competitiveness in the market, and the development of the company is also restricted.
Therefore, enterprises should attach importance to management innovation, efficiently coordinate multi-organization management and build a refined management system.

　　Conclusion

　　In general, with the implementation and advancement of policies such as volume purchases, basic drug catalogs, and medical insurance catalogs, the pharmaceutical equipment industry is ushering in a new round of prosperity.
Enterprises should closely follow the policies and adapt to the changes of the times.
The development direction of the pharmaceutical companies, the new medical reform environment and their own development strategies are seized.
Driven by the policy environment and market demand, comprehensive innovation, research and development, talents and other aspects can be cut from multiple perspectives to enter the market.
Based on an invincible place.

　　Original title: Under the new situation, how can pharmaceutical machinery companies stay behind in the market?

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.